ApprovalTrail

Company · Etobicoke, Ontario, Canada

BGP Pharma ULC

Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.

Drug products (DIN)
146
120 authorized now
Natural health products
2
0 active licences
Medical device licences
0
0 active
Notices of Compliance
160

Drug products

Authorized products first.

NameDINStatus
ANDROGEL02245345Marketed
ANDROGEL02245346Marketed
ANDROGEL02249499Marketed
BIAXIN02146908Marketed
BIAXIN02244641Marketed
BIAXIN BID01984853Marketed
BIAXIN BID02126710Marketed
CADUET02273233Marketed
CADUET02273241Marketed
CADUET02273268Marketed
CADUET02273276Marketed
CADUET02273284Marketed
CADUET02273292Marketed
CADUET02273306Marketed
CADUET02273314Marketed
CELEBREX02239941Marketed
CELEBREX02239942Marketed
CREON MINIMICROSPHERES 1002200104Marketed
CREON MINIMICROSPHERES 2501985205Marketed
CREON MINIMICROSPHERES 3502494639Marketed
CREON MINIMICROSPHERES MICRO02445158Marketed
DEPAKENE00443832Marketed
DETROL02239064Marketed
DETROL02239065Marketed
DETROL LA02244612Marketed
DETROL LA02244613Marketed
DICETEL01950592Marketed
DICETEL02230684Marketed
DILANTIN00022772Marketed
DILANTIN00022780Marketed
DILANTIN INFATABS00023698Marketed
DYMISTA02432889Marketed
EFFEXOR XR02237279Marketed
EFFEXOR XR02237280Marketed
EFFEXOR XR02237282Marketed
EPIVAL00596418Marketed
EPIVAL00596426Marketed
EPIVAL00596434Marketed
INFLUVAC02269562Marketed
INFLUVAC TETRA02484854Marketed
INSPRA02323052Marketed
INSPRA02323060Marketed
ISOPTIN SR01907123Marketed
KADIAN02184435Marketed
KADIAN02184443Marketed
KADIAN02184451Marketed
KADIAN02242163Marketed
KADIAN02559722Marketed
LIPIDIL EZ02269074Marketed
LIPIDIL EZ02269082Marketed
LIPIDIL SUPRA02241602Marketed
LIPITOR02230711Marketed
LIPITOR02230713Marketed
LIPITOR02230714Marketed
LIPITOR02243097Marketed
LUVOX01919369Marketed
LUVOX01919342Marketed
LYRICA02268418Marketed
LYRICA02268426Marketed
LYRICA02268434Marketed
LYRICA02268450Marketed
LYRICA02268477Marketed
LYRICA02268485Marketed
MAVIK02231457Marketed
MAVIK02231459Marketed
MAVIK02231460Marketed
MAVIK02239267Marketed
NEURONTIN02084260Marketed
NEURONTIN02084279Marketed
NEURONTIN02084287Marketed
NEURONTIN02239717Marketed
NEURONTIN02239718Marketed
NITROSTAT00037621Marketed
NITROSTAT00037613Marketed
NORVASC00878928Marketed
NORVASC00878936Marketed
RELPAX02256290Marketed
RELPAX02256304Marketed
REVATIO02279401Marketed
REVATIO02341611Marketed
RYTHMOL00603708Marketed
RYTHMOL00603716Marketed
SERC02243878Marketed
SERC02247998Marketed
SYNTHROID02172070Marketed
SYNTHROID02172062Marketed
SYNTHROID02171228Marketed
SYNTHROID02172119Marketed
SYNTHROID02172089Marketed
SYNTHROID02172151Marketed
SYNTHROID02172143Marketed
SYNTHROID02172127Marketed
SYNTHROID02172097Marketed
SYNTHROID02172135Marketed
SYNTHROID02172100Marketed
SYNTHROID02233852Marketed
TOBI02239630Marketed
TOBI PODHALER02365154Marketed
VIAGRA02239766Marketed
VIAGRA02239767Marketed
VIAGRA02239768Marketed
VIAGRA02544172Marketed
XALACOM02246619Marketed
XALATAN02231493Marketed
XANAX00548359Marketed
XANAX00548367Marketed
XANAX00723770Marketed
XANAX TS00813958Marketed
ZELDOX02298597Marketed
ZELDOX02298600Marketed
ZELDOX02298619Marketed
ZELDOX02298627Marketed
ZOLOFT01962817Marketed
ZOLOFT01962779Marketed
ZOLOFT02132702Marketed
CREON MINIMICROSPHERES 2002494620Approved
ISOPTIN SR00742554Dormant
ISOPTIN SR01934317Dormant
VITAROS02359413Approved
VITAROS02359421Approved
ABBOTT-OLANZAPINE ODT02414538Cancelled Post Market
ABBOTT-QUETIAPINE02412977Cancelled Post Market
ABBOTT-QUETIAPINE02412985Cancelled Post Market
ABBOTT-QUETIAPINE02412993Cancelled Post Market
ABBOTT-QUETIAPINE02413000Cancelled Post Market
ABBOTT-RABEPRAZOLE02422638Cancelled Post Market
ABBOTT-RABEPRAZOLE02422646Cancelled Post Market
ABBOTT-TOPIRAMATE02414600Cancelled Post Market
ABBOTT-TOPIRAMATE02414619Cancelled Post Market
ABBOTT-TOPIRAMATE02414627Cancelled Post Market
AMOXICILLIN02237154Cancelled Pre Market
BIAXIN XL02244756Cancelled Post Market
CREON MINIMICROSPHERES 602415194Cancelled Post Market
DEPAKENE00443840Cancelled Post Market
DILANTIN-125 SUSPENSION00023450Cancelled Post Market
DILANTIN-30 SUSPENSION00023442Cancelled Post Market
HYTRIN00818666Cancelled Post Market
HYTRIN00818658Cancelled Post Market
HYTRIN00818682Cancelled Post Market
HYTRIN00818674Cancelled Post Market
LIPIDIL MICRO02146959Cancelled Post Market
TARKA02238097Cancelled Post Market
TARKA02240946Cancelled Post Market
TEVETEN02240432Cancelled Post Market
TEVETEN02243942Cancelled Post Market
TEVETEN PLUS02253631Cancelled Post Market

Natural health products

Active licences first, newest first.

NameNPNStatus
Creon Micro Minimicrospheres80025751Discontinued
CREON MINIMICROSPHERES ® 2501985205Discontinued

Notices of Compliance

Newest first.

  • TOBI PODHALEROctober 7, 2026 · NOC 38424 · Supplement to a New Drug Submission (SNDS)
  • KADIANAugust 20, 2026 · NOC 38148 · Supplement to a New Drug Submission (SNDS)
  • EPIVALApril 30, 2026 · NOC 37439 · Supplement to a New Drug Submission (SNDS)
  • DEPAKENEApril 30, 2026 · NOC 37440 · Supplement to a New Drug Submission (SNDS)
  • REVATIOApril 21, 2026 · NOC 37371 · Supplement to a New Drug Submission (SNDS)
  • TOBIApril 17, 2026 · NOC 37360 · Supplement to a New Drug Submission (SNDS)
  • SERCMarch 25, 2026 · NOC 37176 · Supplement to a New Drug Submission (SNDS)
  • INFLUVACJanuary 27, 2026 · NOC 36794 · Supplement to a New Drug Submission (SNDS)
  • DETROL LADecember 17, 2025 · NOC 36588 · Supplement to a New Drug Submission (SNDS)
  • LIPIDIL EZDecember 5, 2025 · NOC 36495 · Supplement to a New Drug Submission (SNDS)
  • EPIVALOctober 29, 2025 · NOC 36275 · Supplement to a New Drug Submission (SNDS)
  • DEPAKENEOctober 29, 2025 · NOC 36276 · Supplement to a New Drug Submission (SNDS)
  • INFLUVACAugust 27, 2025 · NOC 35914 · Supplement to a New Drug Submission (SNDS)
  • INFLUVAC TETRAAugust 27, 2025 · NOC 35916 · Supplement to a New Drug Submission (SNDS)
  • ANDROGELAugust 1, 2025 · NOC 35789 · Supplement to a New Drug Submission (SNDS)
  • KADIANJuly 25, 2025 · NOC 35740 · Supplement to a New Drug Submission (SNDS)
  • CADUETJuly 23, 2025 · NOC 35721 · Supplement to a New Drug Submission (SNDS)
  • LIPITORJuly 22, 2025 · NOC 35717 · Supplement to a New Drug Submission (SNDS)
  • CELEBREXJuly 9, 2025 · NOC 35644 · Supplement to a New Drug Submission (SNDS)
  • CADUETJune 20, 2025 · NOC 35557 · Supplement to a New Drug Submission (SNDS)
  • NEURONTINMay 22, 2025 · NOC 35401 · Supplement to a New Drug Submission (SNDS)
  • LYRICAApril 11, 2025 · NOC 35167 · Supplement to a New Drug Submission (SNDS)
  • BIAXIN; BIAXIN BIDDecember 17, 2024 · NOC 34575 · Supplement to a New Drug Submission (SNDS)
  • NORVASCDecember 4, 2024 · NOC 34494 · Supplement to a New Drug Submission (SNDS)
  • INFLUVACNovember 8, 2024 · NOC 34381 · Supplement to a New Drug Submission (SNDS)
  • DYMISTANovember 1, 2024 · NOC 34313 · Supplement to a New Drug Submission (SNDS)
  • SYNTHROIDOctober 8, 2024 · NOC 34157 · Supplement to a New Drug Submission (SNDS)
  • XALATANSeptember 25, 2024 · NOC 34094 · Supplement to a New Drug Submission (SNDS)
  • INFLUVAC TETRASeptember 12, 2024 · NOC 34028 · Supplement to a New Drug Submission (SNDS)
  • EPIVALJune 25, 2024 · NOC 33501 · Supplement to a New Drug Submission (SNDS)
  • DEPAKENEJune 25, 2024 · NOC 33502 · Supplement to a New Drug Submission (SNDS)
  • RYTHMOLApril 29, 2024 · NOC 33134 · Supplement to a New Drug Submission (SNDS)
  • LUVOXApril 26, 2024 · NOC 33119 · Supplement to a New Drug Submission (SNDS)
  • NEURONTINApril 10, 2024 · NOC 33038 · Supplement to a New Drug Submission (SNDS)
  • LYRICAMarch 4, 2024 · NOC 32816 · Supplement to a New Drug Submission (SNDS)
  • VIAGRADecember 28, 2023 · NOC 32429 · Supplement to a New Drug Submission (SNDS)
  • TOBIDecember 6, 2023 · NOC 32299 · Supplement to a New Drug Submission (SNDS)
  • EFFEXOR XROctober 31, 2023 · NOC 31973 · Supplement to a New Drug Submission (SNDS)
  • NEURONTINOctober 17, 2023 · NOC 31870 · Supplement to a New Drug Submission (SNDS)
  • TOBI PODHALEROctober 13, 2023 · NOC 31853 · Supplement to a New Drug Submission (SNDS)
  • CELEBREXSeptember 26, 2023 · NOC 31721 · New Drug Submission (NDS)
  • INFLUVAC TETRASeptember 18, 2023 · NOC 31657 · Supplement to a New Drug Submission (SNDS)
  • ZELDOXSeptember 15, 2023 · NOC 31647 · New Drug Submission (NDS)
  • REVATIOSeptember 11, 2023 · NOC 31596 · New Drug Submission (NDS)
  • RELPAXAugust 30, 2023 · NOC 31527 · New Drug Submission (NDS)
  • DETROLAugust 30, 2023 · NOC 31530 · New Drug Submission (NDS)
  • ZOLOFTAugust 22, 2023 · NOC 31470 · New Drug Submission (NDS)
  • SYNTHROIDAugust 18, 2023 · NOC 31455 · Supplement to a New Drug Submission (SNDS)
  • CADUETAugust 18, 2023 · NOC 31456 · New Drug Submission (NDS)
  • EFFEXOR XRAugust 9, 2023 · NOC 31388 · New Drug Submission (NDS)
  • LIPITORAugust 2, 2023 · NOC 31358 · New Drug Submission (NDS)
  • DILANTIN INFATABS; DILANTIN-125 SUSPENSION; DILANTIN-30 SUSPENSIONAugust 2, 2023 · NOC 31359 · New Drug Submission (NDS)
  • NORVASCAugust 2, 2023 · NOC 31360 · New Drug Submission (NDS)
  • XALATANJuly 31, 2023 · NOC 31333 · New Drug Submission (NDS)
  • VIAGRAJuly 28, 2023 · NOC 31328 · New Drug Submission (NDS)
  • XALACOMJuly 21, 2023 · NOC 31298 · New Drug Submission (NDS)
  • HULIOJuly 20, 2023 · NOC 31302 · Supplement to a New Drug Submission (SNDS)
  • INSPRAJuly 6, 2023 · NOC 31135 · New Drug Submission (NDS)
  • KADIANJune 19, 2023 · NOC 31010 · Supplement to a New Drug Submission (SNDS)
  • DILANTINJune 7, 2023 · NOC 30937 · New Drug Submission (NDS)
  • DETROL LAMay 29, 2023 · NOC 30855 · New Drug Submission (NDS)
  • FULPHILAMay 11, 2023 · NOC 30703 · Supplement to a New Drug Submission (SNDS)
  • LYRICAMay 11, 2023 · NOC 30709 · New Drug Submission (NDS)
  • NEURONTINMay 5, 2023 · NOC 30644 · New Drug Submission (NDS)
  • ABEVMYApril 25, 2023 · NOC 30564 · Supplement to a New Drug Submission (SNDS)
  • XANAX; XANAX TSApril 20, 2023 · NOC 30597 · New Drug Submission (NDS)
  • ABEVMYApril 5, 2023 · NOC 30501 · Supplement to a New Drug Submission (SNDS)
  • FULPHILAMarch 9, 2023 · NOC 30292 · Supplement to a New Drug Submission (SNDS)
  • EPIVALFebruary 8, 2023 · NOC 30078 · Supplement to a New Drug Submission (SNDS)
  • DEPAKENEFebruary 7, 2023 · NOC 30063 · Supplement to a New Drug Submission (SNDS)
  • ABEVMYNovember 23, 2022 · NOC 29531 · Supplement to a New Drug Submission (SNDS)
  • TEVETEN PLUSSeptember 26, 2022 · NOC 29086 · Supplement to a New Drug Submission (SNDS)
  • SEMGLEESeptember 22, 2022 · NOC 29084 · Supplement to a New Drug Submission (SNDS)
  • INFLUVAC TETRASeptember 21, 2022 · NOC 29037 · Supplement to a New Drug Submission (SNDS)
  • FULPHILASeptember 8, 2022 · NOC 28911 · Supplement to a New Drug Submission (SNDS)
  • HULIOAugust 12, 2022 · NOC 28759 · Supplement to a New Drug Submission (SNDS)
  • DEPAKENEJuly 8, 2022 · NOC 28547 · Supplement to a New Drug Submission (SNDS)
  • EPIVALJuly 4, 2022 · NOC 28511 · Supplement to a New Drug Submission (SNDS)
  • DYMISTAMay 18, 2022 · NOC 28209 · Supplement to a New Drug Submission (SNDS)
  • SEMGLEEApril 8, 2022 · NOC 27950 · New Drug Submission (NDS)
  • ISOPTIN SRDecember 9, 2021 · NOC 27201 · Supplement to a New Drug Submission (SNDS)
  • OGIVRIDecember 6, 2021 · NOC 27182 · Supplement to a New Drug Submission (SNDS)
  • INFLUVAC TETRANovember 30, 2021 · NOC 27155 · Supplement to a New Drug Submission (SNDS)
  • DEPAKENENovember 18, 2021 · NOC 27058 · Supplement to a New Drug Submission (SNDS)
  • ABEVMYNovember 5, 2021 · NOC 26998 · New Drug Submission (NDS)
  • BIAXIN; BIAXIN BIDOctober 26, 2021 · NOC 26916 · Supplement to a New Drug Submission (SNDS)
  • EPIVALOctober 15, 2021 · NOC 26851 · Supplement to a New Drug Submission (SNDS)
  • SYNTHROIDOctober 13, 2021 · NOC 26829 · Supplement to a New Drug Submission (SNDS)
  • KIRSTYOctober 12, 2021 · NOC 26827 · New Drug Submission (NDS)
  • INFLUVAC TETRASeptember 22, 2021 · NOC 26708 · Supplement to a New Drug Submission (SNDS)
  • RYTHMOLAugust 27, 2021 · NOC 26521 · Supplement to a New Drug Submission (SNDS)
  • EPIVALAugust 23, 2021 · NOC 26492 · Supplement to a New Drug Submission (SNDS)
  • LUVOXJuly 21, 2021 · NOC 26294 · Supplement to a New Drug Submission (SNDS)
  • HULIOMay 14, 2021 · NOC 25874 · Supplement to a New Drug Submission (SNDS)
  • DEPAKENEMay 7, 2021 · NOC 25820 · Supplement to a New Drug Submission (SNDS)
  • EPIVALMay 6, 2021 · NOC 25819 · Supplement to a New Drug Submission (SNDS)
  • HULIOMarch 11, 2021 · NOC 25428 · Supplement to a New Drug Submission (SNDS)
  • TEVETEN PLUSFebruary 25, 2021 · NOC 25291 · Supplement to a New Drug Submission (SNDS)
  • LIPIDIL EZFebruary 22, 2021 · NOC 25256 · Supplement to a New Drug Submission (SNDS)
  • LUVOXDecember 18, 2020 · NOC 24822 · Supplement to a New Drug Submission (SNDS)

The latest 100 of 160.

Recalls and safety alerts that mention its products

Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.